Abstract
Neurexins constitute a large family of highly variable cell-surface molecules that may function in synaptic transmission and/or synapse formation. Each of the three known neurexin genes encodes two major neurexin variants, alpha- and beta-neurexins, that are composed of distinct extracellular domains linked to identical intracellular sequences. Deletions of one, two, or all three alpha-neurexins in mice recently demonstrated their essential role at synapses. In multiple alpha-neurexin knock-outs, neurotransmitter release from excitatory and inhibitory synapses was severely reduced, primarily probably because voltage-dependent Ca2+ channels were impaired. It remained unclear, however, which neurexin variants actually influence exocytosis and Ca2+ channels, which domain of neurexins is required for this function, and which Ca2+-channel subtypes are regulated. Here, we show by electrophysiological recordings that transgenic neurexin 1alpha rescues the release and Ca2+-current phenotypes, whereas transgenic neurexin 1beta has no effect, indicating the importance of the extracellular sequences for the function of neurexins. Because neurexin 1alpha rescued the knock-out phenotype independent of the alpha-neurexin gene deleted, these data are consistent with a redundant function among different alpha-neurexins. In both knock-out and transgenically rescued mice, alpha-neurexins selectively affected the component of neurotransmitter release that depended on activation of N- and P/Q-type Ca2+ channels, but left L-type Ca2+ channels unscathed. Our findings indicate that alpha-neurexins represent organizer molecules in neurotransmission that regulate N- and P/Q-type Ca2+ channels, constituting an essential role at synapses that critically involves the extracellular domains of neurexins.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
6-Cyano-7-nitroquinoxaline-2,3-dione / pharmacology
-
Animals
-
Animals, Newborn
-
Blotting, Western / methods
-
Brain Stem / cytology
-
Brain Stem / growth & development
-
Brain Stem / metabolism
-
Calcium / metabolism
-
Calcium Channel Blockers / pharmacology
-
Calcium Channels, N-Type / physiology*
-
Calcium Channels, P-Type / physiology*
-
Dose-Response Relationship, Radiation
-
Electric Stimulation / methods
-
Excitatory Amino Acid Antagonists / pharmacology
-
Excitatory Postsynaptic Potentials / drug effects
-
Excitatory Postsynaptic Potentials / physiology
-
Excitatory Postsynaptic Potentials / radiation effects
-
Glycoproteins / chemistry*
-
Glycoproteins / deficiency
-
Glycoproteins / metabolism
-
Horseradish Peroxidase / metabolism
-
Immunoprecipitation / methods
-
Membrane Potentials / drug effects
-
Membrane Potentials / physiology
-
Membrane Potentials / radiation effects
-
Mice
-
Mice, Transgenic
-
Nerve Tissue Proteins / deficiency
-
Nerve Tissue Proteins / metabolism
-
Neural Inhibition / drug effects
-
Neural Inhibition / physiology
-
Neural Inhibition / radiation effects
-
Neurons / drug effects
-
Neurons / physiology
-
Neurons / radiation effects
-
Neuropeptides / chemistry*
-
Neuropeptides / deficiency
-
Neuropeptides / metabolism
-
Patch-Clamp Techniques / methods
-
Protein Structure, Tertiary / physiology*
-
Sodium Channel Blockers / pharmacology
-
Synaptic Transmission / drug effects
-
Synaptic Transmission / physiology*
-
Tetrodotoxin / pharmacology
Substances
-
Calcium Channel Blockers
-
Calcium Channels, N-Type
-
Calcium Channels, P-Type
-
Excitatory Amino Acid Antagonists
-
Glycoproteins
-
Nerve Tissue Proteins
-
Neuropeptides
-
Sodium Channel Blockers
-
neurexophilin
-
neurexin Ibeta
-
Tetrodotoxin
-
6-Cyano-7-nitroquinoxaline-2,3-dione
-
Horseradish Peroxidase
-
Calcium